Colgate-Palmolive Company

NYSE:CL

Household & Personal Products

Consumer Defensive
$98.85 -0.78%

-$0.71 today

Market cap
$78.58B
Beta
0.32
P/E (TTM)
34.5
EPS (TTM)
$2.60
Dividend yield
2.33%
52W Low $74.55High $99.33

Volume 6.07M

Average 5.62M

CL Cash & Equivalents

Cash on hand and highly liquid investments that can be converted to cash almost immediately.

Colgate-Palmolive CompanyNYSE: CL

Cash & Equivalents · Q3 FY2026 · quarter ended Sep 2026

Cash & equivalents rises 19.4% from a year ago

Cash & equivalents stood at $1.53B at the end of Q3 FY2026, up 19.4% from a year earlier and up 11.5% from the prior quarter. Over 3 fiscal years it compounded at +18.5% a year.

Context

  • Cash & equivalents amounted to 9.1% of total assets at the end of Q3 FY2026, up 1.8 pp from a year earlier.
  • Cash & equivalents increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +19.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.53B+11.5% QoQ
Last fiscal yearDec 2025
$1.29B+17.5% YoY
Year agoSep 2025
$1.28B+19.4% since
Cash & Equivalents past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.4%——
1 year+17.5%——
3-year CAGR+18.5%——
5-year CAGR——
10-year CAGR——

Cash & Equivalents history

USD · from the balance sheet

Latest · FY2025
1.29B USD
Year-over-year change
+17.5%
4-year CAGR
+11.5%

Cash & Equivalents vs competitors

How CL compares with its peers on the latest reported figures

  • Peers report in different currencies, so cash & equivalents is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +19.4% is the 4th highest of 7, against a peer median of +24.2%.
  • Cash & equivalents amounts to 9.1% of total assets for CL, versus a peer median of 5.0%.
CL Competitors
Cash & Equivalents for CL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PGThe Procter & Gamble CompanySep 2026$15.37B USD+37.5%+6.4%11.5%
ULUnilever PLCDec 2025€3.94B EUR-35.8%-3.1%5.6%
CLColgate-Palmolive CompanySep 2026$1.53B USD+19.4%+18.5%9.1%
KVUEKenvue Inc.Sep 2026$1.04B USD-8.8%-4.8%3.9%
KMBKimberly-Clark CorporationJun 2026$956M USD+50.8%+17.2%5.2%
CHDChurch & Dwight Co., Inc.Sep 2026$446.9M USD+46.4%+14.8%4.8%
CLXThe Clorox CompanySep 2026$184M USD+10.8%-27.0%2.3%
Peer median (excluding CL) —+24.2%+1.7%5.0%

Competitors are the stored peer set for CL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents832M775M966M1.1B1.29B
Short-term Investments000160M0
Net Receivables1.3B1.5B1.59B1.52B1.68B
Inventory1.69B2.07B1.93B1.99B2.03B
Other Current Assets576M760M793M553M714M
Total Current Assets4.4B5.11B5.28B5.32B5.71B
Property, Plant & Equipment (Net)3.73B4.31B4.58B4.42B4.66B
Goodwill3.28B3.35B3.41B3.27B3.12B
Intangible Assets2.46B1.92B1.89B1.76B1.54B
Long-term Investments00081M0
Tax Assets193M135M214M195M205M
Other Non-current Assets974M904M1.02B1B1.1B
Total Non-current Assets10.64B10.62B11.11B10.73B10.62B
Total Assets15.04B15.73B16.39B16.05B16.33B
Account Payables1.48B1.55B1.7B1.81B2.09B
Short-term Debt51M25M330M660M1.12B
Tax Payables554M450M503M565M0
Deferred Revenue00000
Other Current Liabilities93M97M122M116M118M
Total Current Liabilities4.05B4B4.74B5.76B6.85B
Long-term Debt7.19B8.74B8.22B7.29B6.87B
Deferred Tax Liabilities395M383M361M343M181M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.98B1.4B1.7B1.66B1.61B
Total Non-current Liabilities10.02B10.92B10.7B9.74B9.11B
Total Liabilities14.07B14.93B15.44B15.5B15.97B
Common Stock1.47B1.47B1.47B1.47B1.47B
Retained Earnings24.35B24.57B25.29B26.15B26.6B
Accumulated OCI(4.39B)(4.06B)(3.94B)(4.22B)(3.88B)
Other Stockholders Equity(1M)(1M)000
Minority Interest362M405M348M332M311M
Total Equity971M806M957M544M365M
Total Debt7.83B9.27B9.06B8.51B8.55B
Net Debt7B8.5B8.1B7.42B7.27B

Colgate-Palmolive Company

NYSE:CL

Intrinsic Alpha fair value

Locked

Current Price

$98.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.